Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Services
  3. colorectal cancer
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Locations

  • USA
  • Europe
  • Asia & Middle East
  • North America
Brands

  • mtoz biolabs
  • auspex

Colorectal Cancer Services

8 services found

Colorectal Cancer Program

Colorectal Cancer Program

Manufactured by:BiomX   based inNess Ziona, ISRAEL
Our colorectal cancer program utilizes engineered phage with various payloads (such as immunostimulatory payloads) that are administered intravenously to target Fusobacterium nucleatum bacteria residing within the tumor microenvironment. The aim of payload delivery is to convert cold tumors to hot tumors with activated immune responses. ...
CONTACT SUPPLIER

Auspex - Colorectal Cancer Recurrence and Chemo Efficacy Assay Services

Auspex - Colorectal Cancer Recurrence and Chemo Efficacy Assay Services

by:Auspex Diagnostics   based inWarren, NEW JERSEY (USA)
Auspex Diagnostic’s colorectal cancer test is a revolutionary treatment planning tool that can help stage II and III colorectal cancer patients and doctors personalize the treatment to the individual patient’s genes. Since no two patients are the alike, it is crucial that patients learn as much as possible about ...
CONTACT SUPPLIER

Research Services

Research Services

Manufactured by:IMB Dx, Inc.   based inSeoul, SOUTH KOREA
The AlphaLiquid® platform is being widely applied in translational research to empower our understanding of tumor evolution, response to therapy and resistance mechanisms, as well as to provide insights on the clinical value of ctDNA analysis in precision ...
CONTACT SUPPLIER

Personalized Cancer Treatment Services

Personalized Cancer Treatment Services

by:Auspex Diagnostics   based inWarren, NEW JERSEY (USA)
Until now, cancer patients and caretakers in various stages often face the dilemma when deciding whether or not to receive chemotherapy as part of the treatment for two primary reasons – uncertainty of future cancer relapse and efficacy of chemotherapy. If the cancer has low likelihood of relapse, the patients could be wasting time and money on unnecessary treatment. On the other hand, if a ...
CONTACT SUPPLIER

Development Services

Development Services

Manufactured by:Alfa Scientific Designs, Inc   based inPoway, CALIFORNIA (USA)
ALFA offers development services to include contract product development. technology transfer, and various technological offerings such as latex, lateral flow, and fluorescent methodologies. ALFA develops breakthrough designs produced to the highest quality standards and provides a complete solution for customer specific design, assay development, laboratory and clinical sample testing. ...
CONTACT SUPPLIER

Therapies & Diseases

Therapies & Diseases

by:PharmaBiome AG   based inSchlieren, SWITZERLAND
Leading-edge therapies that leverage the microbiome promise to address a range of serious diseases that currently don’t have adequate solutions. Microbiome-based therapies are de-risked thanks to the established proof-of-concept with fecal matter transplant ...
CONTACT SUPPLIER

MtoZ Biolabs - Gene Knockout for Drug Screening and Target Identification

MtoZ Biolabs - Gene Knockout for Drug Screening and Target Identification

by:MtoZ Biolabs   based in, MASSACHUSETTS (USA)
A key step in drug discovery is target identification—identifying "druggable" biological targets. After a target is identified, it must be validated to demonstrate the functional relationship between the target and disease phenotype while ensuring safety. The drug discovery process is lengthy and costly, but good target validation increases the likelihood of developing effective drugs and ...
CONTACT SUPPLIER

MtoZ Biolabs - Biosimilar Assessment Service

MtoZ Biolabs - Biosimilar Assessment Service

by:MtoZ Biolabs   based in, MASSACHUSETTS (USA)
Biosimilars are biological products that are highly similar to an approved original biological drug (reference or brand drug) without any clinically meaningful differences in quality, safety, or efficacy compared to those approved. Biosimilars typically enter the market after the patent protection period of the original drug has expired, providing a more cost-effective treatment ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT